Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Health Equity PHGKB

Specific PHGKB|Health Equity PHGKB|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Effective August 1, 2024, this database will be discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.

Last Posted: Jul 24, 2024
spot light Spotlight

Training Institute for Dissemination and Implementation Research in Genomics and Precision Public Health (TIDIR-GPPH) Facilitated Course
(Posted Jul 24, 2024 8AM)

From the website: "The Training Institute for Dissemination and Implementation Research in Genomics and Precision Public Health (TIDIR-GPPH) Facilitated Course is being offered in 2024 and is open to all current ORISE fellows and mentors! The course is intended to provide participants with a thorough grounding in conducting dissemination and implementation (D&I) research with a specific focus on genomics and precision public health. TIDIR-GPPH will be a hybrid course including training through open access modules with assigned reading material and office hours and culminating with a 2-day in-person event (September 5-6, 2024)."

Advancing Genomic Cancer Medicine in Rural and Underserved States
(Posted Jul 22, 2024 10AM)

From the article: "In the evolving landscape of oncology, the integration of powerful genomic technologies into practice has ushered in a new era of precision cancer medicine. Complex genomic information such as mutational analyses, transcriptional signatures, and polygenic risk scores have become key diagnostics guiding therapeutic decisions and management of inherited cancer risk. However, the expertise to interpret these data for clinical decision-making remains constrained and is a significant challenge for community oncologists, especially those in rural regions and in medically underserved areas. While physical access to these tests is readily available, poor access to interpretive expertise has become the key limiting factor. "

Equity in action: The Diagnostic Working Group of The Undiagnosed Diseases Network International
(Posted Jul 05, 2024 9AM)

From the abstract: "Rare diseases are recognized as a global public health priority. A timely and accurate diagnosis is a critical enabler for precise and personalized health care. However, barriers to rare disease diagnoses are especially steep for those from historically underserved communities, including low- and middle-income countries. The Undiagnosed Diseases Network International (UDNI) was launched in 2015 to help fill the knowledge gaps that impede diagnosis for rare diseases, and to foster the translation of research into medical practice, aided by active patient involvement. "

Implications of Provider Specialty, Test Type, and Demographic Factors on Genetic Testing Outcomes for Patients with Autism Spectrum Disorder
(Posted Jun 18, 2024 4PM)

From the abstract: "A minority of patients with autism spectrum disorder (ASD) are offered genetic testing by their providers or referred for genetics evaluation despite published guidelines and consensus statements supporting genetics-informed care for this population. This study aimed to investigate the ordering habits of providers of different specialties and to additionally assess the diagnostic utility of genetic testing by test type, patient sex, and race and ethnicity. "


news Latest News and Publications
A Medical Student-Led Multi-Pronged Initiative to Close the Digital Divide in Outpatient Primary Care. External Web Site Icon
Jiangliu Yilan, et al. Applied clinical informatics 2024 0 0.
Lessons learned from a multi-site collaborative working toward a digital health use screening tool. External Web Site Icon
Hernandez Ann M, et al. Frontiers in public health 2024 0 0. 1421129
Factors Associated With Surveillance Testing in Individuals With COVID-19 Symptoms During the Last Leg of the Pandemic: Multivariable Regression Analysis. External Web Site Icon
Dotson Timothy, et al. JMIR public health and surveillance 2024 0 0. e52762
A Multimorbidity Analysis of Hospitalized Patients With COVID-19 in Northwest Italy: Longitudinal Study Using Evolutionary Machine Learning and Health Administrative Data. External Web Site Icon
Benny Dayana, et al. JMIR public health and surveillance 2024 0 0. e52353
Assessing the Relationship Between Neighborhood Socioeconomic Disadvantage and Telemedicine Use Among Patients With Breast Cancer and Examining Differential Provisions of Oncology Services Between Telehealth and In-Person Visits: Quantitative Study. External Web Site Icon
Freeman Jincong Q, et al. JMIR cancer 2024 0 0. e55438
COVID-19 Across Pandemic Variant Periods: The Severe Acute Respiratory Infection-Preparedness (SARI-PREP) Study. External Web Site Icon
Mukherjee Vikramjit, et al. Critical care explorations 2024 0 0. (7) e1122
Household income unequally affects genetic susceptibility to pulmonary diseases: evidence from bidirectional Mendelian randomization study. External Web Site Icon
Xu Hongfa, et al. Frontiers in medicine 2024 0 0. 1279697
Surveillance of adverse events following immunisation in Australia annual report, 2021. External Web Site Icon
Imai Chisato, et al. Communicable diseases intelligence (2018) 2024 0 0.
Impact of class cancellations on parents' and children' adaptation following an outbreak of the Omicron variant during the COVID-19 pandemic in Taiwan in April 2022. External Web Site Icon
Chao Kuo-Yu, et al. BMC public health 2024 0 0. (1) 1902
Nonrepresentativeness of Human Mobility Data and its Impact on Modeling Dynamics of the COVID-19 Pandemic: Systematic Evaluation. External Web Site Icon
Liu Chuchu, et al. JMIR formative research 2024 0 0. e55013
Risk-reducing salpingo-oophorectomy among diverse patients with BRCA mutations at an urban public hospital: a mixed methods study. External Web Site Icon
Alexandra J Lamacki et al. BMJ Open 2024 14(6) e082608
The role of socio-economic disparities in the relative success and persistence of SARS-CoV-2 variants in New York City in early 2021. External Web Site Icon
Tetyana I Vasylyeva et al. PLoS Pathog 2024 6 (6) e1012288
A Paper-Based Multiplexed Serological Test to Monitor Immunity against SARS-COV-2 Using Machine Learning. External Web Site Icon
Eryilmaz Merve, et al. ACS nano 2024 0 0.
Assessing fairness in machine learning models: A study of racial bias using matched counterparts in mortality prediction for patients with chronic diseases. External Web Site Icon
Yifei Wana et al. J Biomed Inform 2024 104677
Digital pathology, deep learning, and cancer: a narrative review. External Web Site Icon
Darnell K Adrian Williams et al. Transl Cancer Res 2024 13(5) 2544-2560
An ethical assessment of professional opinions on concerns, chances, and limitations of the implementation of an artificial intelligence-based technology into the geriatric patient treatment and continuity of care. External Web Site Icon
Nina Parchmann et al. Geroscience 2024
Results from the Delivery of a Community Health Worker Training to Advance Competencies in Cancer Genomics. External Web Site Icon
Caitlin G Allen et al. Public Health Genomics 2024
Artificial Intelligence in the Provision of Health Care: An American College of Physicians Policy Position Paper. External Web Site Icon
Nadia Daneshvar et al. Ann Intern Med 2024
Equity and AI governance at academic medical centers. External Web Site Icon
Paige Nong et al. Am J Manag Care 2024 30(6 Spec No.) SP468-SP472
The impact of health inequity on spatial variation of COVID-19 transmission in England. External Web Site Icon
Rawson Thomas, et al. PLoS computational biology 2024 0 0. (5) e1012141

More

About Health Equity PHGKB

Health Equity PHGKB is an online, continuously updated, searchable database of genomics and precision health information and publications relevant to health equity...more

Content Summary

Quick Links


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP